These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25812292)

  • 21. Evidence-Based Guidelines for EMS Administration of Naloxone.
    Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
    Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of opioid overdose: a brief review of naloxone pharmacology and delivery.
    Hendley TM; Hersh EV; Moore PA; Stahl B; Saraghi M
    Gen Dent; 2017; 65(3):18-21. PubMed ID: 28475079
    [No Abstract]   [Full Text] [Related]  

  • 24. An Overdose Antidote Goes Mainstream.
    Humphreys K
    Health Aff (Millwood); 2015 Oct; 34(10):1624-7. PubMed ID: 26438736
    [No Abstract]   [Full Text] [Related]  

  • 25. Naloxone nasal spray.
    Drug Ther Bull; 2019 Sep; 57(9):137-140. PubMed ID: 31296655
    [No Abstract]   [Full Text] [Related]  

  • 26. FASTER RESPONSE. Hospitals backing increased use of opioid antidote.
    Asplund J
    Hosp Health Netw; 2016 Jan; 90(1):20, 22, 2. PubMed ID: 26904909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Back from the brink: groups urge wide use of opioid antidote to avert overdoses.
    Kuehn BM
    JAMA; 2014 Feb; 311(6):560-1. PubMed ID: 24510187
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
    Glaser A; Arakaki D; Chan GM; Hoffman RS
    Med J Aust; 2005 Apr; 182(8):427; author reply 427, 429. PubMed ID: 15850442
    [No Abstract]   [Full Text] [Related]  

  • 29. Naloxone prescribing: room for finesse.
    Gilham J; Lloyd G
    Br J Hosp Med (Lond); 2019 Mar; 80(3):C46-C48. PubMed ID: 30860915
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacist-led health-system approaches to reduce opioid overdose and death.
    Saldaña SN; Weaver N; Stanford B
    J Am Pharm Assoc (2003); 2017; 57(2S):S8-S9. PubMed ID: 27865761
    [No Abstract]   [Full Text] [Related]  

  • 31. Intranasal Naloxone Administration.
    Ortega R; Nozari A; Baker W; Surani S; Edwards M
    N Engl J Med; 2021 Mar; 384(12):e44. PubMed ID: 33761209
    [No Abstract]   [Full Text] [Related]  

  • 32. Intranasal naloxone for life threatening opioid toxicity.
    Kelly AM; Koutsogiannis Z
    Emerg Med J; 2002 Jul; 19(4):375. PubMed ID: 12101174
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder.
    Herring AA; Schultz CW; Yang E; Greenwald MK
    Am J Emerg Med; 2019 Dec; 37(12):2259-2262. PubMed ID: 31239086
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
    Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
    Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Legislative: Responding to the Fatal Opioid Overdose Epidemic: A Call to Nurses.
    Clark A
    Online J Issues Nurs; 2014 Aug; 19(3):10. PubMed ID: 26824158
    [No Abstract]   [Full Text] [Related]  

  • 36. Naloxone Conundrum: Reduce risk in managing the opioid overdose patient.
    Wirth SR
    JEMS; 2016 Nov; 41(11):14-5. PubMed ID: 29188938
    [No Abstract]   [Full Text] [Related]  

  • 37. Bringing naloxone to ground zero: Huntington, West Virginia.
    Babcock C; Rockich-Winston N; Booth C
    J Am Pharm Assoc (2003); 2017; 57(2S):S9-S10. PubMed ID: 27838389
    [No Abstract]   [Full Text] [Related]  

  • 38. Addressing the Fentanyl Threat to Public Health.
    Frank RG; Pollack HA
    N Engl J Med; 2017 Feb; 376(7):605-607. PubMed ID: 28199808
    [No Abstract]   [Full Text] [Related]  

  • 39. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Diagnosis of drug overdose by rapid reversal with naloxone.
    Barrie J; May G
    Emerg Med J; 2006 Nov; 23(11):874-5. PubMed ID: 17057146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
    Klebacher R; Harris MI; Ariyaprakai N; Tagore A; Robbins V; Dudley LS; Bauter R; Koneru S; Hill RD; Wasserman E; Shanes A; Merlin MA
    Prehosp Emerg Care; 2017; 21(6):682-687. PubMed ID: 28686547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.